Emerging Growth Equities, Ltd. Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an $18.00 Pr...(established companies. For these and oth...)

Date:8/18/2008

established companies. For these and other reasons, the investments discussed or recommended in this report may be unsuitable for investors depending on their specific investment objectives and financial position. Transactions in securities mentioned herein may be effected only in those states where such securities are qualified for sale.

Any statements nonfactual in nature herein constitute only current opinions or estimates, represent only the current judgment of the author(s), and are subject to change without notice. This report contains forward-looking statements, which involve risks and uncertainties. Actual results may differ significantly from the results described in the forward-looking statements. Emerging Growth Equities, Ltd. (or one of its affiliates) or their partners, officers, directors, analysts, employees or customers may have an interest in the securities mentioned herein and may make purchases or sales as principal or agent of these securities, or their derivatives, while this report is in circulation. A partner, employee, analyst, officer, or director of Emerging Growth Equities, Ltd. (or one of its affiliates) may serve as a director or consultant for any company mentioned herein. Emerging Growth Equities, Ltd. (or one of its affiliates) may from time to time perform investment banking services for, or solicit investment banking business or other business from, any company mentioned herein. Additional information on the securities discussed herein is available on request.

Emerging Growth Equities, Ltd. is a member of the Financial Industry Regulatory Authority, CRD number 47040.

'/>"/>

SOURCE Emerging Growth Equities, Ltd. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related biology technology :

1. Oral Drug From Novartis/Mitsubishi Tanabe Will Capture the Largest Market Share of All Emerging Multiple Sclerosis Therapies in 2017
2. BioNanomatrix Named Best Management Team at the 2008 Ben Franklin Emerging Business Awards
3. Pharsight to Present at Jesup and Lamont 2008 Emerging Growth Stock Conference
4. CyberKnife Users Meeting Highlights Major Clinical Data Milestones and Emerging Trends
5. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
6. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
7. NanoMaterials Technology to Conduct Process Development Feasibility Study with US Based Emerging Pharmaceutical Company
8. Project on Emerging Nanotechnologies and Consumers Union collaborate on ConsumersTalkNano
9. Luminex Corporation to Present at Americas Growth Capital Emerging Growth Conference
10. Neurocrine Biosciences to Present at the A.G. Edwards Annual Emerging Growth Conference
11. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference